Value of testing the defibrillation function of ICDSs;Ergebnisse der testung der defibrillationsfunktion implantierbarer kardioverter/defibrillatoren

Zeitschrift fur Kardiologie

Volumn 86, Issue 6, 1997, Pages 450-459

  Brunn, J ^a   Block, M ^a   Weber, M ^a   Bansch D ^a   Seifert, T ^a   Castrucci, M ^a   Isbruch, F ^a   Bocker D ^a   Breithardt, G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Antiarrhythmic drug; Defibrillation; ICD dysfunction; ICD test; Implantable cardioverter defibrillator

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVERSION; CLINICAL TRIAL; DEFIBRILLATION; HEART ARRHYTHMIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CORONARY DISEASE; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTRODES; EQUIPMENT FAILURE ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; VENTRICULAR FIBRILLATION;

EID: 0030851245     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050079     Document Type: Article

References (19)

1. Bakker P, Viens E, de Vries J, Bredee J (1994) Impact of defibrillation threshold testing on cerebral circulation and oxygenation. PACE 17:802 (Abstract)
2. Benedini G, Marchini A, Curnis A, Bianchetti F, Gardini A, Pinetti P, Zanelli E (1995) Implantable defibrillator and thromboembolic event. PACE 18:199-202
3. Dorian P, Newman D (1993) Effect of sotalol on ventricular fibrillation and defibrillation in humans. Am J Card 72:72-79
4. Fastenrath C, Block M, Castrncci M, Böcker D, Isbruch F. Hammel D, Breithardt G, Scheld H (1995) Efficacy of 50 Hz burst and T-wave shock tor induction of ventricular fibrillation during testing implantable cardioverter/defibrillators. PACE 17:864 (Abstract)
5. Gliner BE, Mrakawa Y, Thakor N (1990) The defibrillation success rate versus energy relationship: part I - curve fitting and the most efficient defibrillation energy. PACE 13:226-338
6. Jung W, Manz M, Pfeiffer D, Tebbenjohanns J, Pizzulli L, Lüderitz B (1993) Eftects of antiarrhythmic drugs on epicardial defibrillation requirements and the rate of defibrillator discharges. PACE 16:198 201
7. Kopp D, Kall J, Kinder C, Glascock D, Wilber D (1995) Effect of amiodarone and left ventricular mass on defibrillation energy requirements: monophasic vs biphasic shocks. PACE 18:872 (Abstract)
8. Le Feuvre C, Klein GJ, Sakun V, Sheahan R, Krahn A, Yee R (1995) Is predischarge ICD-defibrillation threshold testing necessary? PACE 18:827 (Abstract)
9. Lüderitz B, Jung W, Deister A, Manz M (1994) Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am Heart J 127:1179-1184
10. Marchlinski F, Flores B, Miller J, Gottlieb C, Hargrove W (1988) Relation of the intraoperative defibrillation tereshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Card 62:393-398
11. May C, Smith P, Murdock C, Davis M (1995) The impact of the implantable cardioverter defibrillator on quality-of-life. PACE 18:1411-1418
12. Mirowski M, Reid P, Mower M, Watkins L, Gott V, Schauble J, Langer A, Heilmann M, Kolenik S, Fischell R, Weisfeldt M (1980) Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 303:322-324
13. Peters W, Gang E, Okazaki H, Solingen S, Kobayashi Y, Karagueuzian H, Mandel W (1991) Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog. Am Heart J 122/5:1355-1360
14. Podczek A, Hief C, Veit E, Jakl G, Kaltenbrunner W, Nürnberg M, Frohner K, Steinbach K (1994) Komplikationen bei transvenös bzw, transvonös subkutan implantierbaren Defibrillatorsystemen. Z Kardiol 83:366-372
15. Schaumann A, Claus I, von zur Mühlen F, Dorszewski A, Gonska BD, Kreuzer H (1996) Effektivität von empirisch programmiertem antitachykardem Pacing. Z kardiol 85:13 (Abstract)
16. Schöhl W, Trappe HJ, Lichtlen PR (1994) Akzeptanz und Lebensqualität nach Implantation eines automatischen Kardioverters/Defibrillators. Z Kardiol 83:927-932
17. Stevens S, Haffajee C, Naccarelli G, Schwartz K, Luceri R, Packer D, Rubin A, Kowey P (Propafenone investigators) (1995) Propafenone does not effect defibrillation thresholds in patients with implantable cardioverter defibrillators. PACE 18:835 (Abstract)
18. Wang M, Dorian P (1989) DLand D sotalol decrease defibrillation energy requirements. PACE 12:1522-1529
19. Zipes D, Jackman W, Heger J, Chilson D, Browne K, Naccarelli G, Rahilly G, Prystowsky E (1982) Clinical transvenous cardioversion of recurrent lifethreatening tachyarrhythmias: Low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 103:789-794